Becton, Dickinson & Co. (BDX)
200.43
+2.03
(+1.02%)
USD |
NYSE |
Dec 11, 16:00
200.45
+0.02
(+0.01%)
After-Hours: 20:00
Becton, Dickinson Cash from Investing (Quarterly): -494.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| ResMed, Inc. | -52.58M |
| West Pharmaceutical Services, Inc. | -63.30M |
| Solventum Corp. | 3.766B |
| Accuray, Inc. | -3.824M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.354B |
| Cash from Financing (Quarterly) | -809.00M |
| Free Cash Flow | 2.67B |
| Free Cash Flow Per Share (Quarterly) | 3.490 |
| Free Cash Flow to Equity (Quarterly) | 323.00M |
| Free Cash Flow to Firm (Quarterly) | 1.152B |
| Free Cash Flow Yield | 4.62% |